Nifty

:

23346.40

Sensex

:

74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Login

Nifty
Sensex

:
:

23346.40
74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

57/99

BSE: 524372 | NSE: ORCHPHARMA

Watchlist

NSE BSE

989.70

18-Sep-2026

Open
High
Low
Previous Close

958.05
999
958.05
958.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

56527
55458659.55
1133
480

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,923.25
683.50
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,141.16
N/A
4.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.46
17.11
14.59

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-26.72
-41.04
-48.82

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-51.84

P:E (Median)

8 Years
5 Years
3 Years

35.64
42.49
58.44

P:BV (Average)

8 Years
5 Years
3 Years

2.81
3.32
3.98

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.01
36.62
40.89

Earnings Forecasts:

(Updated: 19-09-2026)

Description 2026 2027 2028 2029
Adj EPS 27 23 332.38 2.3
P/E Ratio 36.66 43.03 2.98 430.30
Revenue 122.41 22.77 - 803.6
EBITDA 1288.5 1933.8 - 37.2
Net Income 101.4 339.5 - -10.2
ROA 46.8 259.5 - -
P/B Ratio - - - 3.44
ROE 3.29 2.86 - -0.7
FCFF 3 13.5 - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - 288

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 304.17 263.19 15.57% 237.61 237.48 0.05% 207.27 217.34 -4.63% 193.52 222.70 -13.10%
Expenses 289.17 268.82 7.57% 208.61 203.14 2.69% 204.43 190.98 7.04% 194.19 193.11 0.56%
EBITDA 15.00 -5.64 - 28.99 34.33 -15.55% 2.84 26.37 -89.23% -0.67 29.58 -
EBIDTM 4.93% -2.14% 12.20% 14.46% 1.37% 12.13% -0.35% 13.28%
Other Income 10.05 16.05 -37.38% 13.30 6.26 112.46% 10.59 9.94 6.54% 15.43 7.96 93.84%
Interest 2.21 2.29 -3.49% 3.08 3.98 -22.61% 3.17 3.79 -16.36% 3.73 3.30 13.03%
Depreciation 10.90 10.54 3.42% 9.15 8.76 4.45% 8.97 8.61 4.18% 8.79 8.63 1.85%
PBT 11.94 -2.41 - 30.60 27.85 9.87% -5.83 23.91 - 2.23 25.63 -91.30%
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 11.94 -2.41 - 30.60 27.85 9.87% -5.83 23.91 - 2.23 25.63 -91.30%
PATM 3.92% -0.91% 12.88% 11.73% -2.81% 11.00% 1.15% 11.51%
EPS 2.35 -0.47 - 6.04 5.49 10.02% -1.15 4.72 - 0.44 5.05 -91.29%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 304.17 263.19 15.57% 237.61 237.48 0.05% 207.27 217.34 -4.63% 193.52 222.70 -13.10%
Expenses 290.17 268.83 7.94% 210.74 209.49 0.60% 205.70 190.98 7.71% 195.00 192.36 1.37%
EBITDA 14.00 -5.64 - 26.86 27.98 -4.00% 1.56 26.36 -94.08% -1.48 30.34 -
EBIDTM 4.60% -2.14% 11.31% 11.78% 0.75% 12.13% -0.76% 13.62%
Other Income 1.83 11.57 -84.18% 7.34 3.90 88.21% 5.61 8.49 -33.92% 10.77 7.52 43.22%
Interest 2.23 2.29 -2.62% 3.09 3.92 -21.17% 3.18 3.80 -16.32% 3.73 3.33 12.01%
Depreciation 10.95 10.54 3.89% 8.87 8.87 0.00% 9.03 8.61 4.88% 8.90 8.63 3.13%
PBT 2.65 -6.89 - 22.79 19.09 19.38% -12.15 22.45 - -3.33 25.90 -
Tax 0.07 0.00 0 0.00 -0.04 - 0.00 0.00 0 0.00 0.00 0
PAT 2.58 -6.89 - 22.78 19.13 19.08% -12.15 22.45 - -3.33 25.90 -
PATM 0.85% -2.62% 9.59% 8.06% -5.86% 10.33% -1.72% 11.63%
EPS 0.54 -0.95 - 4.69 4.40 6.59% -2.49 4.10 - -1.13 5.37 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 942.57 1,232.78 1,397.61 819.37 665.90 556.97 450.69 481.21 583.65 644.17 755.36 Net Sales Growth 0.20% -11.79% 70.57% 23.05% 19.56% 23.58% -6.34% -17.55% -9.40% -14.72% Cost Of Goods Sold 631.31 844.46 893.35 484.46 384.62 314.07 229.27 200.31 278.16 330.87 367.46 Gross Profit 311.26 388.32 504.26 334.91 281.28 242.90 221.42 280.90 305.49 313.30 387.89 GP Margin 33.02% 31.50% 36.08% 40.87% 42.24% 43.61% 49.13% 58.37% 52.34% 48.64% 51.35% Total Expenditure 896.40 1,224.68 1,259.75 708.57 581.60 498.27 391.92 469.81 589.95 621.96 663.28 Power & Fuel Cost - 89.62 100.07 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 % Of Sales - 7.27% 7.16% 7.68% 9.20% 9.47% 8.72% 9.86% 8.35% 7.87% 7.19% Employee Cost - 114.32 109.23 69.64 65.35 60.21 64.40 71.60 79.14 82.39 75.44 % Of Sales - 9.27% 7.82% 8.50% 9.81% 10.81% 14.29% 14.88% 13.56% 12.79% 9.99% Manufacturing Exp. - 60.66 61.95 39.75 35.55 32.88 29.09 50.71 54.64 63.08 85.12 % Of Sales - 4.92% 4.43% 4.85% 5.34% 5.90% 6.45% 10.54% 9.36% 9.79% 11.27% General & Admin Exp. - 26.05 26.79 22.22 14.26 10.80 15.23 42.43 28.21 38.52 38.42 % Of Sales - 2.11% 1.92% 2.71% 2.14% 1.94% 3.38% 8.82% 4.83% 5.98% 5.09% Selling & Distn. Exp. - 27.97 36.58 23.86 14.34 20.35 11.52 6.42 7.40 14.62 35.43 % Of Sales - 2.27% 2.62% 2.91% 2.15% 3.65% 2.56% 1.33% 1.27% 2.27% 4.69% Miscellaneous Exp. - 61.60 31.78 5.72 6.22 7.22 3.10 50.91 93.64 41.79 35.43 % Of Sales - 5.00% 2.27% 0.70% 0.93% 1.30% 0.69% 10.58% 16.04% 6.49% 0.94% EBITDA 46.16 8.10 137.86 110.80 84.30 58.70 58.77 11.40 -6.30 22.21 92.08 EBITDA Margin 4.90% 0.66% 9.86% 13.52% 12.66% 10.54% 13.04% 2.37% -1.08% 3.45% 12.19% Other Income 49.37 86.53 49.75 30.65 19.43 9.00 6.46 24.28 16.93 19.87 19.48 Interest 12.19 9.32 13.25 16.71 32.90 33.46 52.21 6.22 6.68 310.25 331.10 Depreciation 37.81 43.36 41.91 33.22 54.79 87.02 108.90 117.91 129.92 133.29 139.42 PBT 38.94 41.95 132.45 91.52 16.04 -52.77 -95.87 -88.46 -125.99 -401.47 -358.96 Tax 0.00 0.00 -9.45 -3.23 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 Tax Rate 0.00% 0.00% -7.13% -3.53% 0.00% 0.00% 0.00% 0.00% 0.00% 11.51% 9.04% PAT 38.94 34.62 141.90 94.75 55.25 -52.77 -95.87 -88.46 -101.05 -355.28 -483.63 PAT before Minority Interest 38.94 34.62 141.90 94.75 55.25 -52.77 -95.87 -88.46 -101.05 -355.28 -483.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.13% 2.81% 10.15% 11.56% 8.30% -9.47% -21.27% -18.38% -17.31% -55.15% -64.03% PAT Growth -48.07% -75.60% 49.76% 71.49% - - - - - - EPS 7.68 6.83 27.99 18.69 10.90 -10.41 -18.91 -17.45 -19.93 -70.07 -95.39

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 942.57 1,232.78 1,397.61 819.37 665.90 559.56 450.06 483.80 599.98 682.98 796.50 Net Sales Growth 0.20% -11.79% 70.57% 23.05% 19.00% 24.33% -6.97% -19.36% -12.15% -14.25% Cost Of Goods Sold 631.31 844.46 893.35 484.46 384.62 313.56 228.51 203.35 289.70 350.20 393.46 Gross Profit 311.26 388.32 504.26 334.91 281.28 246.00 221.56 280.45 310.28 332.79 403.05 GP Margin 33.02% 31.50% 36.08% 40.87% 42.24% 43.96% 49.23% 57.97% 51.72% 48.73% 50.60% Total Expenditure 901.61 1,228.89 1,259.76 708.58 581.60 504.98 399.40 453.61 611.80 658.68 709.37 Power & Fuel Cost - 89.62 100.07 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 % Of Sales - 7.27% 7.16% 7.68% 9.20% 9.43% 8.73% 9.81% 8.13% 7.42% 6.82% Employee Cost - 117.65 109.23 69.64 65.35 63.28 67.11 74.86 82.28 86.22 80.25 % Of Sales - 9.54% 7.82% 8.50% 9.81% 11.31% 14.91% 15.47% 13.71% 12.62% 10.08% Manufacturing Exp. - 61.31 61.95 39.75 35.55 32.88 29.10 53.25 55.98 65.65 87.40 % Of Sales - 4.97% 4.43% 4.85% 5.34% 5.88% 6.47% 11.01% 9.33% 9.61% 10.97% General & Admin Exp. - 26.25 26.79 22.22 14.26 13.03 18.34 43.67 30.72 41.49 40.99 % Of Sales - 2.13% 1.92% 2.71% 2.14% 2.33% 4.08% 9.03% 5.12% 6.07% 5.15% Selling & Distn. Exp. - 27.99 36.58 23.86 14.34 22.26 13.46 8.14 10.34 22.10 26.19 % Of Sales - 2.27% 2.62% 2.91% 2.15% 3.98% 2.99% 1.68% 1.72% 3.24% 3.29% Miscellaneous Exp. - 61.61 31.79 5.73 6.22 7.22 3.59 22.89 94.02 42.34 26.19 % Of Sales - 5.00% 2.27% 0.70% 0.93% 1.29% 0.80% 4.73% 15.67% 6.20% 3.36% EBITDA 40.94 3.89 137.85 110.79 84.30 54.58 50.66 30.19 -11.82 24.30 87.13 EBITDA Margin 4.34% 0.32% 9.86% 13.52% 12.66% 9.75% 11.26% 6.24% -1.97% 3.56% 10.94% Other Income 25.55 66.46 38.95 31.13 19.43 9.00 15.21 24.28 16.93 20.30 19.17 Interest 12.23 9.34 13.25 16.74 32.90 33.46 52.21 6.23 6.69 310.26 331.11 Depreciation 37.75 43.25 42.02 33.24 54.79 87.02 108.92 117.93 129.94 133.31 141.02 PBT 9.96 17.76 121.53 91.95 16.04 -56.90 -95.25 -69.69 -131.52 -398.96 -365.82 Tax 0.07 -0.19 -9.64 -3.12 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 Tax Rate 0.70% -1.82% -7.93% -3.39% 0.00% 0.00% 0.00% 0.00% 0.00% 11.58% 8.92% PAT 9.88 10.62 131.17 95.06 55.25 -56.90 -95.25 -69.69 69.41 -352.77 -490.49 PAT before Minority Interest 9.88 10.62 131.17 95.06 55.25 -56.90 -95.25 -69.69 69.41 -352.77 -490.49 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.05% 0.86% 9.39% 11.60% 8.30% -10.17% -21.16% -14.40% 11.57% -51.65% -61.58% PAT Growth -83.69% -91.90% 37.99% 72.05% - - - - - - EPS 1.95 2.09 25.87 18.75 10.90 -11.22 -18.79 -13.75 13.69 -69.58 -96.74

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,646.68 1,610.74 1,218.32 731.96 677.95 681.34 797.83 -754.99 -674.13 -263.83 Share Capital 15.30 15.30 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 Total Reserves 1,586.79 1,550.85 1,167.60 691.15 637.14 640.52 757.01 -843.95 -763.10 -352.80 Non-Current Liabilities 55.92 14.77 124.21 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 Secured Loans 35.63 0.03 0.00 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 Unsecured Loans 0.00 10.00 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 Long Term Provisions 13.45 4.70 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 Current Liabilities 395.04 460.52 209.67 326.63 193.83 100.87 133.18 2,312.71 1,980.28 1,519.64 Trade Payables 276.38 284.55 179.39 129.11 120.74 68.74 60.21 269.93 326.85 403.68 Other Current Liabilities 29.97 30.12 14.15 53.09 47.25 25.76 69.72 1,343.66 958.10 476.00 Short Term Borrowings 87.89 143.00 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 Short Term Provisions 0.80 2.86 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 Total Liabilities 2,097.64 2,086.03 1,552.20 1,223.26 1,094.18 1,224.47 1,449.99 2,993.25 3,210.77 3,460.76 Net Block 670.60 688.29 616.43 573.06 583.65 670.39 857.86 1,161.35 1,291.28 1,401.71 Gross Block 1,493.69 1,477.78 1,297.02 1,220.45 1,176.26 1,175.97 1,246.98 1,424.57 1,424.57 2,893.25 Accumulated Depreciation 823.09 789.50 680.59 647.39 592.60 505.58 389.12 263.22 133.29 1,491.54 Non Current Assets 1,216.19 1,009.49 769.91 729.46 711.12 682.22 885.22 2,209.79 2,519.97 2,507.72 Capital Work in Progress 168.08 43.91 24.46 46.09 9.78 7.43 25.61 278.16 271.53 288.31 Non Current Investment 87.59 79.58 69.40 50.12 49.01 0.40 0.34 0.47 124.77 124.66 Long Term Loans & Adv. 289.91 197.69 59.61 60.20 68.66 3.98 1.41 759.97 822.41 686.62 Other Non Current Assets 0.02 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 6.42 Current Assets 881.44 1,076.54 782.29 493.79 369.78 421.40 564.77 783.46 690.80 953.03 Current Investments 0.00 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 Inventories 372.31 457.37 264.23 228.74 172.66 150.57 140.78 167.11 184.94 197.45 Sundry Debtors 381.35 353.05 189.37 211.91 160.23 131.96 66.38 140.73 145.06 246.42 Cash & Bank 66.51 185.28 257.23 22.34 4.21 18.97 172.32 324.17 301.04 256.04 Other Current Assets 61.26 10.03 6.80 3.64 32.69 104.89 185.29 151.45 59.75 253.12 Short Term Loans & Adv. 49.46 70.81 64.67 27.17 19.83 95.63 163.95 127.86 40.31 244.22 Net Current Assets 486.40 616.02 572.62 167.16 175.95 320.53 431.59 -1,529.25 -1,289.49 -566.61 Total Assets 2,097.63 2,086.03 1,552.20 1,223.25 1,080.90 1,103.62 1,449.99 2,993.25 3,210.77 3,460.75

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,564.31 1,553.93 1,169.47 688.65 647.38 652.91 765.98 -704.04 -791.76 -387.67 Share Capital 15.30 15.30 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 Total Reserves 1,504.42 1,494.05 1,118.75 647.83 606.56 612.09 725.17 -793.00 -880.72 -476.63 Non-Current Liabilities 202.62 14.67 124.43 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 Secured Loans 184.74 0.03 0.22 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 Unsecured Loans 0.00 10.00 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 Long Term Provisions 13.45 4.70 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 Current Liabilities 491.21 508.66 259.97 371.89 240.78 142.08 174.94 2,345.54 2,012.51 1,540.72 Trade Payables 346.71 336.16 229.58 174.37 167.68 109.95 101.59 302.45 358.79 424.52 Other Current Liabilities 55.81 26.60 14.27 53.09 47.25 25.76 70.10 1,343.97 958.40 476.24 Short Term Borrowings 87.89 143.04 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 Short Term Provisions 0.80 2.86 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 Total Liabilities 2,258.14 2,077.26 1,553.87 1,225.21 1,110.56 1,237.25 1,459.90 3,077.03 3,125.37 3,358.00 Net Block 692.13 707.75 620.23 573.09 583.70 670.45 857.93 1,256.26 1,386.20 1,496.54 Gross Block 1,516.87 1,498.65 1,300.94 1,220.56 1,176.39 1,176.10 1,247.11 1,519.52 1,519.16 3,005.92 Accumulated Depreciation 824.73 790.90 680.71 647.47 592.68 505.66 389.18 263.26 132.96 1,509.38 Non Current Assets 1,329.16 979.84 763.12 724.20 712.91 687.39 890.58 2,309.57 2,446.42 2,478.86 Capital Work in Progress 413.60 80.71 30.67 46.46 9.78 7.43 25.61 278.16 271.53 288.31 Non Current Investment 66.97 59.90 45.82 44.44 45.49 0.40 0.34 0.47 1.07 0.96 Long Term Loans & Adv. 156.45 131.45 66.38 60.20 73.93 9.10 6.70 764.84 777.64 686.62 Other Non Current Assets 0.02 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 6.42 Current Assets 928.97 1,097.43 790.75 501.01 384.36 429.01 569.32 767.46 678.94 879.14 Current Investments 0.00 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 Inventories 372.31 457.37 264.23 228.74 172.66 152.89 141.69 169.77 193.74 211.25 Sundry Debtors 381.35 353.05 195.55 215.19 170.57 135.70 67.97 119.89 119.51 203.00 Cash & Bank 83.52 200.63 266.57 30.63 8.06 19.91 174.04 325.52 305.55 257.06 Other Current Assets 91.79 10.87 7.05 3.95 33.08 105.49 185.62 152.28 60.14 207.82 Short Term Loans & Adv. 75.02 75.51 57.36 22.50 20.07 95.87 164.05 140.27 40.31 198.36 Net Current Assets 437.76 588.76 530.78 129.12 143.58 286.92 394.39 -1,578.08 -1,333.57 -661.58 Total Assets 2,258.13 2,077.27 1,553.87 1,225.21 1,097.27 1,116.40 1,459.90 3,077.03 3,125.36 3,358.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 142.42 63.54 130.73 13.39 89.57 24.36 80.42 15.18 5.58 317.68 PBT 34.62 132.45 91.52 54.19 -4.81 -117.15 -149.84 -101.05 -401.47 -445.42 Adjustment 26.71 34.63 41.68 54.10 38.24 163.69 174.58 235.19 449.77 575.53 Changes in Working Capital 78.70 -88.39 -3.22 -94.60 58.04 -27.10 45.25 -114.68 -35.68 187.56 Cash after chg. in Working capital 140.02 78.68 129.99 13.69 91.47 19.44 70.00 19.46 12.62 317.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.40 -15.15 0.74 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -116.32 -50.80 -315.81 -26.70 112.93 67.21 167.12 45.48 -27.95 -8.62 Net Fixed Assets -140.08 -200.21 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 Net Investments -8.01 -10.18 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 Others 31.77 159.59 -241.59 54.91 149.16 -6.90 -263.15 -72.19 -1,513.30 -0.64 Cash from Financing Activity -40.74 2.68 167.07 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.12 Net Cash Inflow / Outflow -14.64 15.41 -18.01 17.86 -14.30 -73.42 -2.79 60.36 11.02 -57.07 Opening Cash & Equivalents 15.94 0.53 18.31 0.45 14.75 88.17 90.97 30.60 19.58 313.11 Closing Cash & Equivalent 1.30 15.94 0.29 18.31 0.45 14.75 88.17 90.97 30.60 256.04

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 125.64 51.37 125.99 18.34 92.47 23.59 80.80 12.02 9.18 317.01 PBT 10.43 121.53 89.05 46.32 -1.95 -116.53 -131.07 69.41 -398.96 -452.28 Adjustment 41.98 40.32 44.15 51.38 36.77 172.15 139.57 57.34 453.49 582.11 Changes in Working Capital 70.88 -95.33 -7.84 -79.06 59.57 -36.96 61.89 -110.44 -38.31 187.17 Cash after chg. in Working capital 123.28 66.52 125.36 18.64 94.38 18.66 70.38 16.30 16.22 317.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.35 -15.15 0.63 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -276.88 -36.48 -312.03 -31.21 112.94 67.21 167.11 45.47 -28.06 -8.59 Net Fixed Assets -140.08 -200.21 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 Net Investments -8.01 -10.18 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 Others -128.79 173.91 -237.81 50.40 149.17 -6.90 -263.16 -72.20 -1,513.41 -0.61 Cash from Financing Activity 137.14 2.46 167.04 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.30 Net Cash Inflow / Outflow -14.10 17.34 -19.00 18.29 -11.39 -74.20 -2.42 57.20 14.51 -57.88 Opening Cash & Equivalents 21.18 3.83 22.60 4.31 15.69 89.89 92.31 35.11 20.60 314.94 Closing Cash & Equivalent 7.07 21.18 3.60 22.60 4.31 15.69 89.89 92.31 35.11 257.06

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 1047.18 1023.69 240.21 179.33 166.10 166.93 195.47 -84.86 -75.78 -29.66 ROA 1.66% 7.80% 6.83% 4.77% -4.55% -7.17% -6.74% -3.26% -10.65% -13.03% ROE 2.19% 10.19% 9.72% 7.84% -7.76% -12.96% -699.60% 0.00% 0.00% 0.00% ROCE 2.49% 9.35% 8.96% 8.77% -1.86% -3.50% -7.48% -3.77% -3.40% -6.44% Fixed Asset Turnover 0.83 1.01 0.65 0.56 0.47 0.37 0.36 0.41 0.30 0.26 Receivable days 108.72 70.83 89.38 101.99 95.74 80.31 78.55 89.36 110.08 148.10 Inventory Days 122.82 94.23 109.80 110.01 105.91 117.98 116.77 110.08 107.53 97.12 Payable days 121.22 94.78 116.21 118.55 110.10 102.64 113.51 182.54 192.92 181.33 Cash Conversion Cycle 110.32 70.28 82.96 93.45 91.55 95.64 81.81 16.91 24.69 63.90 Total Debt/Equity 0.08 0.10 0.11 0.45 0.40 0.66 0.71 -4.28 -4.75 -11.77 Interest Cover 4.72 10.99 6.48 2.68 -0.58 -0.84 -23.07 -14.12 -0.29 -0.61

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 993.34 986.56 230.58 168.72 158.61 159.96 187.67 -79.14 -89.00 -43.58 ROA 0.49% 7.22% 6.84% 4.73% -4.85% -7.06% -5.78% 2.24% -10.88% -13.59% ROE 0.70% 9.79% 10.23% 8.27% -8.75% -13.43% -423.17% 0.00% 0.00% 0.00% ROCE 1.11% 8.95% 9.35% 9.11% -2.32% -3.53% -6.47% 3.08% -3.46% -6.93% Fixed Asset Turnover 0.82 1.00 0.65 0.56 0.48 0.37 0.35 0.39 0.30 0.27 Receivable days 108.72 71.64 91.49 105.72 99.89 82.59 70.86 72.82 85.57 115.97 Inventory Days 122.82 94.23 109.80 110.01 106.18 119.45 117.49 110.57 107.46 102.41 Payable days 147.58 115.57 152.17 162.30 161.59 168.95 136.49 197.80 198.57 186.30 Cash Conversion Cycle 83.97 50.29 49.12 53.43 44.47 33.09 51.86 -14.40 -5.54 32.07 Total Debt/Equity 0.20 0.10 0.12 0.48 0.41 0.69 0.74 -4.59 -4.04 -8.01 Interest Cover 2.12 10.17 6.49 2.68 -0.70 -0.82 -20.04 11.38 -0.29 -0.63

Top Investors:

quant mutual fund - quant small cap fund

kotak mahindra trustee co ltd a/c kotak consumption fund and 7 others

uti small cap fund and 3 others

invesco india contra fund and 2 others

bandhan small cap fund and 5 others

Annual Reports:

News Update:

Orchid Pharma signs licensing and supply agreement with Pharmasyntez
8th Jul 2026, 09:16 AM

Under the agreement, Pharmasyntez will hold the exclusive rights to register and commercialize Exblifep in Russia, with Orchid supplying the finished dosage form
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback